The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter- defibrillators

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 3, 2011, Pages 324-330

  Scott, Paul A ^a,b   Morgan, John M ^a,b   Carroll, Nicola ^b   Murday, David C ^b   Roberts, Paul R ^b   Peebles, Charles R ^a   Harden, Stephen P ^a   Curzen, Nick P ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Arrhythmias cardiac; Coronary artery disease; Death sudden; Implantable cardioverter defibrillators; MRI

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; RADIOISOTOPE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART LEFT VENTRICULAR SCAR; HEART VENTRICLE ARRHYTHMIA; HUMAN; LATE GADOLINIUM ENHANCEMENT CARDIAC MAGNETIC RESONANCE IMAGING; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCAR; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; HEART VENTRICLE; HEART VENTRICLE TACHYCARDIA; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PILOT STUDY; PROGNOSIS;

AGED; CICATRIX; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PILOT PROJECTS; PROGNOSIS; RADIOISOTOPES; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 80052311517     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.959544     Document Type: Article

References (37)

1. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med. 2007;147:251-262. (Pubitemid 351664582)
2. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm. 2008;5:934-955.
3. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowsky EN. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT Study. J Am Coll Cardiol. 2007;50:1150-1157. (Pubitemid 47375017)
4. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357:21-28. (Pubitemid 32056497)
5. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, Judd RM. Reproducibility of chronic infarct size measurement by contrastenhanced magnetic resonance imaging. Circulation. 2002;106:2322-2327. (Pubitemid 35244732)
6. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94:730-736. (Pubitemid 351744690)
7. Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, Schoenhagen P, Starling RC, Flamm SD, Desai MY. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging. 2009;2:34-44.
8. Roes SD, Kelle S, Kaandorp TAM, Kokocinski T, Poldermans D, Lamb HJ, Boersma E, van der Wall EE, Fleck E, de Roos A, Nagel E, Bax JJ. Comparison of myocardial infarct size assessed with contrastenhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol. 2007;100:930-936. (Pubitemid 47368098)
9. Haqqani HM, Marchlinski FE. Electrophysiologic substrate underlying postinfarction ventricular tachycardia: characterization and role in catheter ablation. Heart Rhythm. 2009;6:S70-S76.
10. National Institute for Health and Clinical Excellence. Guidance on implantable cardioverter defibrillators. National Institute for Health and Clinical Excellence Web site. http://www.nice.org.uk/Guidance/TA95. Accessed July 1, 2010.
11. National Institute for Health and Clinical Excellence. Cardiac resynchronisation therapy for the treatment of heart failure. National Institute for Health and Clinical Excellence Web site. http://www.nice.org.uk/Guidance/ TA120. Accessed July 1, 2010.
12. Rosset A, Spadola L, Ratib O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging. 2004; 17:205-216. (Pubitemid 40378992)
13. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002;18:539-542.
14. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation. 2006;113:776-782.
15. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. Prophylactic use of an implantable cardioverter- defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488. (Pubitemid 39603155)
16. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-241.
17. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis part III: multivariate data analysis- choosing a model and assessing its adequacy and fit. Br J Cancer. 2003;89:605-611. (Pubitemid 37076159)
18. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008;52:541-550.
19. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006; 113:2733-2743. (Pubitemid 43947991)
20. de Luna AB, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151-159. (Pubitemid 19043766)
21. Solomon SD, Zelenkofske S, McMurray JJV, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA; the Valsartan in Acute Myocardial Infarction Trial I. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352: 2581-2588. (Pubitemid 41007844)
22. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson PA, Levy WC. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation. 2007;116:392-398. (Pubitemid 47196544)
23. Bello D, Fieno DS, Kim RJ. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005; 45:1104-1108. (Pubitemid 40432446)
24. Bolick D, Hackel D, Reimer K, Ideker R. Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. Circulation. 1986; 74:1266-1279. (Pubitemid 17189246)
25. Miller JM, Harken AH, Hargrove WC, Josephson ME. Pattern of endocardial activation during sustained ventricular tachycardia. J Am Coll Cardiol. 1985;6:1280-1287. (Pubitemid 16171974)
26. de Bakker JM, van Capelle FJ, Janse MJ, Wilde AA, Coronel R, Becker AE, Dingemans KP, van Hemel NM, Hauer RN. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988;77: 589-606. (Pubitemid 18073351)
27. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104: 1101-1107. (Pubitemid 32830391)
28. Kim R, Wu E, Rafael A. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
29. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006;114:32-39. (Pubitemid 44305272)
30. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, Lima JAC, Wu KC. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115:2006-2014. (Pubitemid 46625951)
31. Roes SD, Borleffs CJW, van der Geest RJ, Westenberg JJM, Marsan NA, Kaandorp TAM, Reiber JHC, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ. Infarct tissue heterogeneity assessed with contrastenhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging. 2009;2:183-190.
32. Klocke FJ, Wu E, Lee DC. "Shades of gray" in cardiac magnetic resonance images of infarcted myocardium: can they tell us what we'd like them to? Circulation. 2006;114:8-10. (Pubitemid 44305268)
33. Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol. 2009;55:1-16.
34. Amado LC, Gerber BL, Gupta SN, Rettmann DW, Szarf G, Schock R, Nasir K, Kraitchman DL, Lima JAC. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol. 2004;44:2383-2389. (Pubitemid 39647614)
35. Boogers MJ, Borleffs CJW, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55:2769-2777.
36. Makikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J. 2005;26:762-769. (Pubitemid 40547078)
37. Jepsen P, Johnsen SP, Gillman MW, Sørensen HT. Interpretation of observational studies. Heart. 2004;90:956-960. (Pubitemid 39005959)